slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 16,051-16,080
Pages 788
Rows per page 30
Component
16,051-16,080 of 23,622
19
The slide outlines two distinct treatment arms involving Imdusiran, VTP-300, and Nivolumab.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
24
The slide outlines a sequential dose-escalation study design.Arbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
06
The slide uses a hub-and-spoke visual arrangement around a central patient image.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a circular, iterative process diagram to represent the business strategy.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
09
The slide uses a 3D-like growth chart to illustrate simultaneous expansion strategies.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
14
The slide outlines a clinical trial protocol timeline.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
15
The slide outlines a clinical trial protocol with a 1-3 week screening phase followed by a 30-week treatment period.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Loop · Why Now1 hit
17
Includes a biological mechanism diagram on the left and a clinical trial design timeline on the right.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
18
The slide uses a hub-and-spoke style network visualization to represent partnerships.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
20
The diagram uses a hub-and-spoke layout with the company logo at the center.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
22
Clinical trial design schematic showing randomization, screening criteria, and study endpoints.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
23
Clinical trial design diagram showing randomization, treatment arms (Efgartigimod vs Placebo), concomitant OCS usage, and interim analysis point.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
24
The slide outlines a multi-phase clinical trial structure with specific patient cohorts (IMNM, ASyS, DM) and a GO/NO-GO decision point.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
25
Clinical trial design diagram showing patient flow from screening through randomization to treatment and follow-up.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
04
The slide uses a timeline-based clinical trial design framework.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
The slide uses a pyramid layout to represent market segments by patient population size.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
03
arm | Investor Presentation Deck | 8 slidesarm | Investor Presentation Deck | 8 slides · Arm
Conference presentation Investor relations 1 hit
03
The slide uses a visual arrow diagram to contrast H1 headwinds with H2 profit/cash generation.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Situation & Context1 hit
14
The slide uses a three-stage horizontal progression to outline strategic financial priorities.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Solution & Approach1 hit
17
The slide uses a central hub-and-spoke model to connect strategic pillars (Destination for style, Best product, Customer journey, Competitive convenience) to specific operational metrics.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Solution & Approach1 hit
22
The diagram represents a continuous cycle of stock management.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Evidence & Proof1 hit
46
The slide uses a color-coded timeline to map KPIs to time horizons, emphasizing a shift from short-term performance to long-term brand health.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations 1 hit
65
The diagram uses color-coded nodes to categorize different business levers (product, customer, operational, etc.) feeding into the central goal.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations 1 hit
13
The slide uses a two-column layout to contrast data integration (AZBrain) with specific application use cases.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Loop · Logic Chain1 hit
16
The slide uses a dual-column layout to contrast a strategic roadmap for Tagrisso with a competitive performance chart for Calquence.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
18
Includes waterfall plots for two patient cohorts and a trial design schematic.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
24
Uses a custom matrix-like layout to show drug combinations and monotherapies against disease prevalence segments.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
25
Includes a bar chart for UACR reduction and a mechanism-of-action/pipeline diagram for tozorakimab.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
26
Includes a navigation bar at the top indicating the current section is 'BioPharmaceuticals'.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
The slide uses a matrix-like structure to map patient risk profiles against treatment lines, highlighting specific drug trials (e.g., SERENA, CAPItello, CAMBRIA, DESTINY).AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit